Roivant Sciences (ROIV) Q3 2024 Earnings
ROIV·Reported November 12, 2024·Before market open·FQ2 FY2025
Roivant Sciences reported Q3 2024 revenue of $4.5M, missed analyst consensus of $45.9M by $41.4M. Diluted EPS came in at $-0.29, missed the $-0.25 consensus by $0.04.
Revenue
$4.5Mmissed by $41.4M
Consensus: $45.9MDiluted EPS
$-0.29missed by $0.04
Consensus: $-0.25
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Roivant Sciences's Q3 2024 earnings report.
Roivant Sciences (ROIV) reported Q3 2024 earnings on November 12, 2024 before market open.
Roivant Sciences reported revenue of $4.5M and diluted EPS of $-0.29 for Q3 2024.
Revenue missed the consensus estimate of $45.9M by $41.4M. EPS missed the consensus estimate of $-0.25 by $0.04.
You can read the 10-Q periodic report (0001140361-24-046019) directly on SEC EDGAR. The filing index links above go to sec.gov.